RyanF.P.Human endogenous retroviruses in health and disease: a symbiotic perspective.J R Soc Med2004; 97: 560–5
2.
PerrillatF., ClavelJ., AuclercM.F.. Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control study.Br J Cancer2002; 86: 1064–9
3.
PfahlbergA., KölmelK.F., GrangeJ.M.. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study.J Invest Dermatol2002; 119: 570–5
4.
KroneB., KölmelK.F., GrangeJ.M.. Impact of vaccinations and infectious diseases on melanoma risk—evaluation of an EORTC case–control study.Eur J Cancer2003; 39: 2372–8
5.
KölmelK.F., GrangeJ.M., KroneB.. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.Eur J Cancer2005; 41: 118–25
6.
SchiavettiF., ThonnardJ., ColanD.. A human endogenous retroviral sequence encoding antigen recognized on melanoma by cytolytic T lymphocytes.Cancer Res2002; 62: 5510–16
7.
KroneB., KölmelK.F., HenzB.M., GrangeJ.M.Protection against melanoma by vaccination with Bacille Calmette–Guérin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.Eur J Cancer2005; 41: 104–17